Complete cytogenetic response with host-derived hematopoiesis induced by cyclosporin A discontinuation in a patient with relapsed chronic myelogenous leukemia after bone marrow transplantation

Bone Marrow Transplantation

Volumn 20, Issue 7, 1997, Pages 615-617

  Suzuki, R ^a   Taji, H ^a   Iida, S ^a   Miura, K ^a   Kagami, Y ^a   Ogura, M ^a   Yatabe, Y ^a   Nakamura, S ^a   Seto, M ^a   Morishima, Y ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Allogeneic bone marrow transplantation; Chronic myelogenous leukemia; Complete cytogenetic response; Cytogenetic relapse; Discontinuation of immunosuppression; Graft failure

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; CANCER RECURRENCE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INTRAVENOUS DRUG ADMINISTRATION; KARYOTYPE 46,XX; LEUKEMIA CELL; MALE; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0030712395     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700929     Document Type: Article

References (12)

1. Thomas ED, Clift RA, Feter A et al. Marrow transplantation for the treatment of chronic myelogenous leukemia. Ann Intern Med 1986; 104: 155-163.
2. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase: increased risk of relapse associated T-cell depletion. Ann Intern Med 1988; 108: 806-814.
3. Mrsic M, Horowitz MM. Atkinson K et al. Second HLA-identical sibling transplants for leukemia recurrence. Bone Marrow Transplant 1992; 9: 269-275.
4. Higano CS, Raskind WH, Singer JW. Use of α interferon for the treatment of relapse of chronic myelogenous leukemia in chronic phase after bone marrow transplantation. Blood 1992; 79: 1437-1442.
5. Kolb HJ, Mittermuller J, Clemm C et al. Donor leukocyte transfusions for treatment of recurrence of chronic myelogenous leukemia in marrow transplant patients. Blood 1990; 12: 2462-2465.
6. Porte LD, Roth MS, McGarigle C et al. Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New Engl J Med 1994; 330: 100-106.
7. Collins RH Jr, Rogers ZR, Bennett M et al. Hematologic relapse of chronic myelogenous leukemia following allogeneic bone marrow transplantation: apparent graft-versus-leukemia effect following abrupt discontinuation of immunosuppression. Bone Marrow Transplant 1992; 10: 391-395.
8. Wakui M, Okamoto S, Ishida A et al. Durable molecular remission in a patient with chronic myelogenous leukemia and host-derived hematopoiesis after allogeneic bone marrow transplantation. Bone Marrow Transplant 1996; 18: 801-804.
9. Frassoni F, Strada P, Sessarego M et al. Mixed chimerism after allogeneic marrow transplantation for leukemia: correlation with dose of total body irradiation and graft-versus-host disease. Bone Marrow Transplant 1990; 5: 235-240.
10. Bretagne S, Vidaud M, Kuentz M et al. Mixed blood chimerism in T cell-depleted bone marrow transplant recipients: evaluation using DNA polymorphisms. Blood 1987; 70: 1692-1695.
11. Fishleder AJ, Bolwell B, Lichtin AE. Incidence of mixed chimerism using busulfan/cyclophosphamide containing regimens in allogeneic bone marrow transplantation. Bone Marrow Transplant 1992; 9: 293-297.
12. Baranov AE, Selidovkin GD, Butturini A, Gale RP. Hematopoietic recovery after 10-Gy acute total body radiation. Blood 1994; 83: 596-599.